Kevin O’Driscoll

With over 20 years in the biophar­ma­ceu­tical industry, Kevin is considered an agile and accomplished leader. He has held diverse roles across the research, business, and operational channels, offering comprehensive scientific and commercial experience to Double Rainbow. His proven track record in business development, corporate strategy, new product planning and private and public fundraising, is key to Double Rainbow’s growth strategy.

Prior to joining Double Rainbow, Kevin was the Senior Director of Business Development and Licensing at Pulmatrix where throughout a 12-year tenure, he played an integral role in taking the company public. His leadership responsibilities included corporate strategy, valuation, accretion/​dilution modeling, commercial and market assessment evaluations, in-licensing and out-licensing, and research collaborations.

Prior to joining Pulmatrix, Kevin was a Scientist at Alkermes and was responsible for early preclinical testing of the company’s lead development programs for pharmaceuticals and pharmacodynamic evaluations of proprietary pulmonary drug delivery technology. He began his career as a Researcher at The Harvard School of Public Health.

Kevin holds a Bachelor of Science degree in biology from Saint Michael’s College, and an MBA, Global Management from Babson F.W. Olin Graduate School of Business.